Igyxos

Nouzilly, France

Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.

$6.7M raised

Oct 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Igyxos raised?

Igyxos has raised $6.7M in total funding. The most recent round was Grant. The last funding was announced in October 2025.

Who are Igyxos's investors?

Igyxos's investors include Bpifrance, GO CAPITAL, France 2030, Sofimac Innovation.

Where is Igyxos headquartered?

Igyxos is headquartered in Nouzilly, France.

What does Igyxos do?

Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.

What stage is Igyxos at?

Igyxos is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 2, 2025.

MLA

"Igyxos — Funding & Investors." VCBacked, October 2, 2025, https://www.vcbacked.co/company/igyxos. Accessed July 5, 2026.

APA

VCBacked. (2025). Igyxos — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/igyxos

Wikipedia (cite web)

{{cite web |title=Igyxos — Funding & Investors |url=https://www.vcbacked.co/company/igyxos |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 2, 2025.